Winter Olympic Games the Kvitfjell downhill arena. For the 2026 Winter Games, IOC allowed Stockholm to have the alpine event in Åre, away (road distance). In 1967 the IOC began enacting drug testing protocols. They started by randomly testing athletes at the 1968 Winter Olympics. The first Winter Games athlete to test positive for a banned substance was Alois Schloder, a West German hockey player, but his team was still allowed to compete. During the 1970s testing outside of competition was escalated because it was found to deter athletes from using performance-enhancing drugs. The problem with testing during this time was a lack
Drug reaction testing Drug reaction testing Drug reaction testing uses a genetic test to predict how a particular person will respond to various prescription and non-prescription medications. It checks for genes that code for specific liver enzymes which activate, deactivate, or are influenced by various drugs. There are currently four genetic markers commonly tested for: 2D6, 2C9, 2C19, and 1A2. This testing has been done for some time by drug companies working on new drugs, but is relatively newly available to the general public. Strattera is the first drug to mention the test in the official documentation, although it doesn't specifically recommend that